Section 66
Chapter 65,144

Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?

Asselah, T; Marcellin, P; Schinazi, R F.

Liver International 38: 7-13


ISSN/ISBN: 1478-3223
DOI: 10.1111/liv.13673
Accession: 065143441

Download citation:  

Around 71 million people are chronically infected with Hcv worldwide. Hcv antiviral drug development has been remarkable. The availability of pangenotypic direct-acting antivirals with excellent efficacy and good tolerability profiles offer a unique opportunity to achieve Hcv elimination worldwide. IFN-free Daa combinations can now cure Hcv in more than 95% of patients with Hcv infection after 8-12 weeks of treatment.

PDF emailed within 0-6 h: $19.90